Closed

NHS Framework Agreement for Branded Pharmaceuticals for London - Tranche B and Interim Biosimilars for Midlands & East, North of England and South of England

NHS England · £710,890,000 · closes 29 Jun 2017

£710,890,000

Estimated value

Closed

Deadline

30 May 2017

Published

This tender has closed.

See what's open in medical equipment and pharmaceuticals, or get contracts like this in your inbox each morning — free.

Set up free alertsOpen medical equipment and pharmaceuticals tenders

About this contract

NHS Framework Agreement for Branded Pharmaceuticals for London - Tranche B and Interim Biosimilars for Midlands & East, North of England and South of England Offer reference number: CM/PHR/14/5446 Period of framework agreement: CM/PHR/14/5446/01 - 1 September 2017 - 31 August 2019 with an option to extend for up to 24 months CM/PHR/14/5446/02 - North of England 1September 2017 - 28 February 2018 with an option to extend for up to 6 months South of England - 1 September 2017 - 31 August 2018 with an option to extend for up to 12 months Midlands and East - 1 September 2017 - 28 February 2019 with an option to extend for up to 18 months Additional information: The procurement exercise is being conducted on the NHS England eTendering portal at www.nhsengland.bravosolution.co.uk the project code is tender_616 and the ITT code is itt_285. This is where the ITO documents are available.

Key dates

Published30 May 2017
Submission deadline29 Jun 2017 Add to calendar ↓

Source

Tender documents portalOpen ↗
Source notice on Contracts FinderView ↗

Who to contact

NameMichelle Clarke

Tender documents

tenderNoticeOpen ↗
tenderNoticeOpen ↗
tenderNoticeOpen ↗
tenderNoticeOpen ↗
tenderNoticeOpen ↗
tenderNoticeOpen ↗
tenderNoticeOpen ↗
tenderNoticeOpen ↗
tenderNoticeOpen ↗
tenderNoticeOpen ↗
tenderNoticeOpen ↗
tenderNoticeOpen ↗

Similar open tenders

Contains public sector information licensed under OGL v3.0